Expanding the Multipotent Profile of Huprine-Tacrine Heterodimers as Disease-Modifying Anti-Alzheimer Agents

Publisher： Karger

E-ISSN： 1660-2862|10|1-4|96-99

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.10, Iss.1-4, 2012-01, pp. : 96-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How Can We Improve Transfer of Outcomes from Randomized Clinical Trials to Clinical Practice with Disease-Modifying Drugs in Alzheimer's Disease?

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-08 ,pp. : 197-199

Karger

Access to resources Recommend Favorite

Huprine X and Huperzine A Improve Cognition and Regulate Some Neurochemical Processes Related with Alzheimer’s Disease in Triple Transgenic Mice (3xTg-AD)

By  

Neurodegenerative Diseases, Vol. 11, Iss. 3, 2012-05 ,pp. : 129-140

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

By  

Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. : 231-235

Karger

Access to resources Recommend Favorite

Therapeutic Effect of Mesenchymal Multipotent Stromal Cells on Memory in Animals with Alzheimer-Type Neurodegeneration

By Bobkova N.   Poltavtseva R.   Samokhin A.   Sukhikh G.  

Bulletin of Experimental Biology and Medicine, Vol. 156, Iss. 1, 2013-11 ,pp. : 119-121

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis in Alzheimer's disease—an update

By Shimohama S.  

Apoptosis, Vol. 5, Iss. 1, 2000-02 ,pp. : 9-16

Springer Publishing Company

Access to resources Recommend Favorite